tiprankstipranks
Advertisement
Advertisement

DE:B72 Stock Latest News

Psychedelic: AtaiBeckley reports publication of BPL-003 study results
The FlyPsychedelic: AtaiBeckley reports publication of BPL-003 study results
6d ago
PBM
ATAI
AtaiBeckley announces peer-reviewed Phase 2a results of BPL-003 study
PremiumThe Fly
AtaiBeckley announces peer-reviewed Phase 2a results of BPL-003 study
8d ago
ATAI
Psychedelic: Clearmind completes treatment, follow-up for CMND-100 trial
PremiumThe Fly
Psychedelic: Clearmind completes treatment, follow-up for CMND-100 trial
13d ago
ATAI
CMND
AtaiBeckley initiated with a Buy at Deutsche Bank
PremiumThe Fly
AtaiBeckley initiated with a Buy at Deutsche Bank
20d ago
ATAI
AtaiBeckley initiated with a Buy at Deutsche Bank
PremiumThe Fly
AtaiBeckley initiated with a Buy at Deutsche Bank
20d ago
ATAI
Psychedelic: Compass Pathways, NRx Pharma report earnings results
PremiumThe FlyPsychedelic: Compass Pathways, NRx Pharma report earnings results
20d ago
ATAI
CMPS
ATAI Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
ATAI Earnings Report this Week: Is It a Buy, Ahead of Earnings?
23d ago
ATAI
Psychedelic: AtaiBeckley reports publication of BPL-003 study results
Premium
The Fly
Psychedelic: AtaiBeckley reports publication of BPL-003 study results
27d ago
ATAI
CMND
AtaiBeckley: Advancing BPL-003 Into Pivotal Phase 3 With Strategic Optionality and Strong Cash Runway Supporting a Buy Rating
PremiumRatings
AtaiBeckley: Advancing BPL-003 Into Pivotal Phase 3 With Strategic Optionality and Strong Cash Runway Supporting a Buy Rating
28d ago
ATAI
Buy Rating on BPL-003 Underpinned by Strong Phase 2a Efficacy, De-Risked Phase 3 Program, and Upside to $25 Target Price
PremiumRatings
Buy Rating on BPL-003 Underpinned by Strong Phase 2a Efficacy, De-Risked Phase 3 Program, and Upside to $25 Target Price
29d ago
ATAI
Atai Beckley announces publication of Phase 2a BPL-003 study results
PremiumThe Fly
Atai Beckley announces publication of Phase 2a BPL-003 study results
30d ago
ATAI
Psychedelic: Clearmind advances recruitment for CMND-100 trial’s third cohort
PremiumThe Fly
Psychedelic: Clearmind advances recruitment for CMND-100 trial’s third cohort
1M ago
ATAI
CMND
Atai Beckley advancing BPL-003 nasal spray towards Phase 3 after FDA meeting
PremiumThe FlyAtai Beckley advancing BPL-003 nasal spray towards Phase 3 after FDA meeting
1M ago
ATAI
ATAI Life Sciences: Reiterating Buy on BPL-003’s Differentiated TRD Profile, Pricing Power, and Long-Dated IP Protection
Premium
Ratings
ATAI Life Sciences: Reiterating Buy on BPL-003’s Differentiated TRD Profile, Pricing Power, and Long-Dated IP Protection
1M ago
ATAI
Atai Beckley reports Q4 EPS ($1.73) vs. (24c) last year
Premium
The Fly
Atai Beckley reports Q4 EPS ($1.73) vs. (24c) last year
1M ago
ATAI
Atai Beckley sees cash runway into 2029
PremiumThe Fly
Atai Beckley sees cash runway into 2029
1M ago
ATAI
Psychedelic: Helus Pharma reports HLP004 Phase 2 signal detection study results
PremiumThe Fly
Psychedelic: Helus Pharma reports HLP004 Phase 2 signal detection study results
1M ago
PBM
ATAI
AtaiBeckley says aligned with FDA on dual-trial design Phase 3 BPL-003 program
PremiumThe Fly
AtaiBeckley says aligned with FDA on dual-trial design Phase 3 BPL-003 program
1M ago
ATAI
Psychedelic: AtaiBeckley reports EMP-01 met primary objective in Phase 2a trial
PremiumThe Fly
Psychedelic: AtaiBeckley reports EMP-01 met primary objective in Phase 2a trial
2M ago
PFE
ABBV
Buy Rating on ATAI Life Sciences Driven by Promising Phase 2a EMP-01 Efficacy and Differentiated Dosing in Social Anxiety Disorder
PremiumRatingsBuy Rating on ATAI Life Sciences Driven by Promising Phase 2a EMP-01 Efficacy and Differentiated Dosing in Social Anxiety Disorder
2M ago
ATAI
Atai Beckley says EMP-01 met primary safety objectivein Phase 2a trial
Premium
The Fly
Atai Beckley says EMP-01 met primary safety objectivein Phase 2a trial
2M ago
ATAI
Psychedelic: Exclusive talk with nonprofit organization MAPS
Premium
The Fly
Psychedelic: Exclusive talk with nonprofit organization MAPS
2M ago
ATAI
CMND

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >